台股 » 個股 » 中裕 » 籌碼相關 » 融資融券與借券

中裕

(4147)
可現股當沖
  • 股價
    86.0
  • 漲跌
    ▼1.5
  • 漲幅
    -1.71%
  • 成交量
    560
  • 產業
    上櫃 生技醫療類股
  • 316人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

中裕 (4147) 融資融券與借券

中裕 (4147) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
12/11636,7749.92-2320.0520.360.4786-1.71%560
12/10516,7119.83-1340.05000.5187.5-2.89%1,193
12/09-496,6609.765350.0510.050.5390.12.85%1,852
12/062956,7099.833300.04000.4587.63.06%2,912
12/05-346,4149.40270.04000.4285-0.35%373
12/04-36,4489.440270.04000.4285.31.19%444
12/0396,4519.450270.04000.4284.30.12%639
12/021496,4429.440270.0410.140.4284.2-0.12%694
11/29-226,2939.220270.0420.230.4384.32.80%864
11/28-446,3159.25-1270.04000.4382-1.91%444
11/27-416,3599.31-7280.0410.240.4483.6-0.36%418
11/26406,4009.37-8350.05000.5583.9-1.29%648
11/2546,3609.3214430.06000.68856.38%2,318
11/22-46,3569.310290.0420.70.4679.90.25%287
11/21-86,3609.320290.04000.4679.70.89%167
11/2076,3689.331290.04000.46790.51%209
11/1936,3619.321280.04000.4478.6-0.13%195
11/18-266,3589.31-6270.04000.4278.7-2.24%412
11/15-226,3849.350330.05000.5280.5-0.62%270
11/14-106,4069.38-5330.05000.5281-0.86%332
11/1396,4169.4-1380.06000.5981.7-0.97%714
11/12-126,4079.380390.06000.6182.50.12%553
11/11-1306,4199.41390.06000.6182.42.87%1,040
11/08336,5499.59-1380.06000.5880.1-1.84%595
11/07-356,5169.54-2390.06000.681.60.99%379
11/0606,5519.6-1410.0610.270.6380.8-0.98%366
11/05-206,5519.6-1420.0610.440.6481.60.00%226
11/04-46,5719.630430.0610.320.6581.6-1.45%313
11/01-476,5759.636430.0610.160.6582.81.72%636
10/30-956,6229.72370.0510.090.5681.40.62%1,116
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
12/11200-232@Limit20.05181050-875,21486-1.71%560
12/10320-134@Limit20.0530590-295,30187.5-2.89%1,193
12/09050535@Limit20.0525570-325,33090.12.85%1,852
12/06030330@Limit20.04461370-915,36287.63.06%2,912
12/05000027@Limit20.041000105,45385-0.35%373
12/04000027@Limit20.0418510-335,44385.31.19%444
12/03000027@Limit20.04231090-865,47684.30.12%639
12/02000027@Limit20.0440045,56284.2-0.12%694
11/29000027@Limit20.043260-235,55884.32.80%864
11/28100-127@Limit20.0492720-2635,58182-1.91%444
11/27700-728@Limit20.0432010-1985,84483.6-0.36%418
11/26800-835@Limit20.0580086,04283.9-1.29%648
11/2511501443@Limit20.066800686,034856.38%2,318
11/22000029@Limit20.041514015,96679.90.25%287
11/21000029@Limit20.04129035,96579.70.89%167
11/20010129@Limit20.041514015,962790.51%209
11/19120128@Limit20.0426540-285,96178.6-0.13%195
11/18600-627@Limit20.0467960-295,98978.7-2.24%412
11/15000033@Limit20.057660-596,01880.5-0.62%270
11/14500-533@Limit20.05291330-1046,07781-0.86%332
11/13100-138@Limit20.068550-476,18181.7-0.97%714
11/12000039@Limit20.0619310-126,22882.50.12%553
11/11010139@Limit20.066650-596,24082.42.87%1,040
11/08100-138@Limit20.069100-16,29980.1-1.84%595
11/07200-239@Limit20.068500-426,30081.60.99%379
11/06100-141@Limit20.0621100116,34280.8-0.98%366
11/05100-142@Limit20.0611750-646,33181.60.00%226
11/04330043@Limit20.0633380-56,39581.6-1.45%313
11/01060643@Limit20.0626750-496,40082.81.72%636
10/30020237@Limit20.0582420406,44981.40.62%1,116
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
12/11907,800,2007,846,40016.07513.33
12/1034330,413,70030,398,20028.75-45.19
12/0928425,168,90025,296,70015.33450
12/0684174,160,10074,409,20028.88296.2
12/05675,704,0005,722,80017.96280.6
12/04968,111,2008,155,90021.62465.63
12/0318415,629,20015,708,30028.79429.89
12/0212810,864,60010,879,70018.44117.97
11/2918215,253,30015,280,60021.06150
11/28917,464,8007,466,40020.517.58
11/2712110,132,20010,148,80028.95137.19
11/2612010,119,90010,127,10018.5260
11/2532927,381,70027,744,50014.191102.74
11/22534,259,4004,263,60018.4779.25
11/21282,218,8002,221,50016.7796.43
11/20312,442,3002,454,40014.83390.32
11/19463,609,0003,616,00023.59152.17
11/18846,645,1006,660,70020.39185.71
11/15544,367,2004,369,3002038.89
11/14614,960,2004,960,90018.3711.48
11/1314111,553,40011,558,10019.7533.33
11/1212910,623,40010,607,30023.33-124.81
11/1116613,361,30013,563,70015.961219.28
11/081139,111,3009,117,40018.9953.98
11/07564,573,1004,582,10014.78160.71
11/06473,818,4003,828,90012.84223.4
11/05403,267,6003,271,00017.785
11/04473,868,3003,872,80015.0295.74
11/0113811,332,00011,357,30021.7183.33
10/3044136,484,60036,554,60039.52158.73
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章